InfuSystem Holdings Inc. (INFU) reported that its fourth-quarter net income was $0.2 million, equal to $0.01 per share, compared to a net loss of $0.8 million or $0.04 per share, in the prior year period.
Revenues in the fourth quarter were $16.2 million, up 16% from $14.0 million in the fourth quarter of 2011.
For the full year ended December 31, 2012, the company's net loss was $1.5 million, or $0.07 per share, versus a net loss of $45.4 million, or $2.16 per share, in 2011. The prior- year period included a $67.6 million asset impairment charge.
Total revenues for the year were $58.8 million, an 8% improvement from $54.6 million in 2011. The increase in revenues was primarily related to the addition of larger customers, increased penetration into existing customer accounts, and the resolution of the oncology drug shortage from 2011.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.